AFVLX
Price
$21.55
Change
-$0.03 (-0.14%)
Updated
Jun 5 closing price
Net Assets
619.87M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

AFVLX vs RMEBX

Header iconAFVLX vs RMEBX Comparison
Open Charts AFVLX vs RMEBXBanner chart's image
Applied Finance Select Investor
Price$21.55
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets619.87M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
AFVLX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFVLX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFVLX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. AFVLX (620M). RMEBX pays higher dividends than AFVLX: RMEBX (1.16) vs AFVLX (0.86). AFVLX was incepted earlier than RMEBX: AFVLX (8 years) vs RMEBX (11 years). AFVLX (1.44) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. AFVLX (6.99). RMEBX has a lower initial minimum investment than AFVLX: RMEBX (250) vs AFVLX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. AFVLX (-0.16). AFVLX return over 5 years is better than : 63.82 vs. RMEBX (49.85).
AFVLXRMEBXAFVLX / RMEBX
Total Expense Ratio1.001.0793%
Annual Report Gross Expense Ratio1.441.07135%
Fund Existence8 years11 years-
Gain YTD0.7945.34915%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets620M105B1%
Annual Yield % from dividends0.861.1674%
Returns for 1 year-0.168.30-2%
Returns for 3 years17.6517.9698%
Returns for 5 years63.8249.85128%
Returns for 10 yearsN/A68.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA